After extending upon September’s spectacular gains of 22.6% into mid-month and testing the highs from early 2018, the Canadian Cannabis LP Index sank 25.1% in October to 939.04:

The index had run up from 2018 lows in mid-August after the announcement of the pending C$5 billion investment by Constellation Brands (NYSE: STZ) into Canopy Growth (TSX: WEED) (NYSE: CGC) ahead of the legalization in Canada on October 17th. An increase in the supply of stock due to new LPs and capital raises from existing ones, disappointment in the initial roll out of legalization, a failure of deals involving Diageo and Coca-Cola to materialize and overall market weakness left the index down 6.5% in 2018, though still well above the August lows:

Supply of stock was a big story during the month, with Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) raising C$75 million by selling Units at C$6.85, Tilray (NASDAQ: TLRY), which isn’t in the index, selling $475 million in convertible notes, Wayland Group (CSE: WAYL) (OTC: MRRCF) raising C$50 million selling units, Supreme Cannabis (TSXV: FIRE) (OTC: SPRWF) issuing C$100 million in convertible notes and Namaste Technologies (TSXV: N) (OTC: NXTTF) selling almost C$52 million Units at C$3.00. Aurora Cannabis (TSX: ACB) (NYSE: ACB) uplisted from the OTC in the U.S., while Aphria (TSX: APH) (OTC: APHQF) announced it will do so on November 2nd, when it begins trading as “APHA” on the NYSE. It will also change its TSX symbol to “APHA”. Canopy Growth announced the acquisition of intellectual property from Colorado-based ebbu. Health Canada issued 12 licenses during the month, leaving the total at 132. Several of these were awarded to publicly-traded companies.

The index, which included 40 publicly-traded licensed producers that traded in Canada at the end of September, with equal weighting, is rebalanced monthly. Each of the members is also included in a sub-index, with four in the Canadian Cannabis LP Tier 1 Index twenty-seven in the Canadian Cannabis LP Tier 2 Index and nine in the Canadian Cannabis LP Tier 3 Index during the month.

Tier 1

Tier 1, which includes the LPs that are generating sales of at least C$4 million per quarter, fell 22.8% in October and is now up 35.9% year-to-date. This group included Aphria, Aurora Cannabis, CannTrust (TSX: TRST) (OTC: CNTTF) and Canopy Growth. Within the group, Aphria had the best return at -12.8%, though its -16.0% return is the lowest among the four year-to-date. Canopy Growth’s 62.8% year-to-date return leads the group.

Tier 2

Tier 2, which includes the remaining LPs that are permitted to generate sales, declined 26.0% and is now down 16.3% year-to-date. TerrAscend (CSE: TER) (OTC: TRSSF) posted a return of 42.2% after it announced its intention to commence operations in the U.S. Green Organic Dutchman declined 57.0%, with substantial insider selling ahead of lock-up expirations for investors prior to the IPO on November 2nd. Aurora Cannabis was also a seller of the stock after declining to exercise an option to buy shares at a 10% discount. Recent new issue The Flowr Corp (TSXV: FLWR) (OTC: FLWPF) fell more than 40%.

Tier 3

Tier 3, which includes the LPs that are licensed to cultivate but not yet approved to sell, fell 23.7% and is now up 2.2% year-to-date. The best performer from this group was MPX Bioceutical (CSE: MPX) (OTC: MPXEF), which declined 4.0% and received a stock-based acquisition offer for its U.S. assets from iAnthus Capital (CSE: IAN) (OTC: ITHUF). Canada House Wellness (CSE: CHV) (OTC: SARSF) performed the worst among the group with its 49.4% decline.

The returns for the overall sector varied greatly, with only TerrAscend increasing in value , while eight declined by more than 33%:

For November, the overall index had five additions, including Biome Grow (CSE: BIO) (OTC: ORTFD), Choom (CSE: CHOO) (OTC: CHOOF), Heritage Cannabis (CSE: CANN) (OTC: HERTF), MediPharm Labs (TSXV: LABS) (OTC: MLCPF) and Valens GroWorks (CSE: VGW) (OTC: MYMSF), all of which has been added to Tier 3. Readers should be aware that Tilray, with no Canadian listing, is not eligible for inclusion in the index, which is denominated in Canadian dollars.

In the next monthly review, we will summarize the performance for November and discuss any additions or deletions. Be sure to bookmark the pages to stay current on LP stock price movements within the day or from day-to-day.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA Facebook | LinkedIn | Email Based in Houston, Alan leverages his experience as founder of online communities 420 Investor , the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures , he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha , where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter